FDA Drug recall D-0645-2018
TM #1 (ALP 5.9/PAPAV 17.65/PHEN 0.59) Injectable solution, packaged in 3 mL amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Easter…
- FDA Drug
- Class II
- terminated
- Published 2018-04-25
On 2018-04-25 the FDA classified a Class II recall of TM #1 (ALP 5.9/PAPAV 17.65/PHEN 0.59) Injectable solution, packaged in 3 mL amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Easter… by Partell Specialty Pharmacy, citing lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0645-2018 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2018-03-22 |
| Published | 2018-04-25 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Partell Specialty Pharmacy |
| Distribution | NV |
Product
TM #1 (ALP 5.9/PAPAV 17.65/PHEN 0.59) Injectable solution, packaged in 3 mL amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800
Reason
Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
Identifiers
| code_info | Lot#: 20180212@22, BUD 03/29/2018; 20180226@64, BUD 04/02/2018. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0645-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.